ViralClear Expands Ongoing Phase 2 Trial Size for its Oral Anti-Viral for the Treatment of COVID-19, Expands Trial Locations and Appoints Contract Manufacturing Organization to Manufacture Phase 3 Supplies of Merimepodib Oral Solution

Press/Media: Expert Comment

PeriodSep 22 2020

Media coverage

12

Media coverage

Keywords

  • COVID-19